Compare Elastic NV (ESTC) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Elastic NV vs IDEXX Laboratories, Inc. — how do they compare? Elastic NV trades at $77.12 (market cap $7.94B), while IDEXX Laboratories, Inc. trades at $569.65 (market cap $46.22B). The key difference: IDEXX Laboratories, Inc. is far larger — about 5.8× Elastic NV's market cap, and Elastic NV is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| ESTC | IDXX | |
|---|---|---|
Market Cap | $7.94B | $46.22B |
Sector | Technology | Health |
52-Week High | $94.47 | $766.68 |
52-Week Low | $43.30 | $526.44 |
Enterprise Value | $7.16B | $47.12B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Elastic (ESTC) trades at $76.64, up 0.42% today, with a bullish technical outlook as it trades above key moving averages. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.61 exceeding the $0.561 estimate. Recent news highlights include a collaboration with OpenAI and recognition as a leader in Gartner's Magic Quadrant for Observability Platforms. Revenue growth is robust, projected to rise from $1.48B in 2025 to $1.7B in 2026, while net income is expected to turn positive at $368M.
The stock offers growth potential driven by AI partnerships and market leadership, but faces risks from high valuation multiples like a P/E of 22.26 and EV/EBITDA of 206.43. Analyst consensus is bullish with a $74.21 price target and no sell ratings, though RSI levels indicate overbought conditions. Key risks include competitive pressures and reliance on tech sector demand.
IDEXX Laboratories (IDXX) trades at $571.44, down 4.08% over the past day, amid a mixed technical and strong fundamental backdrop. The stock shows a bullish trend in moving averages but overbought RSI readings near 73. Recent Q2 2026 earnings beat expectations with 9% organic revenue growth, and the company raised full-year EPS guidance. Profitability remains robust with a 25.03% net income margin and 74.21% ROE.
The outlook is positive given strong earnings momentum, high analyst buy ratings, and a consensus price target of $683.33 implying ~20% upside. Risks include premium valuation multiples and potential market volatility. The stock presents a growth opportunity supported by durable competitive advantages in veterinary diagnostics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Elastic NV
Elastic NV provides a leading search AI platform built on Elasticsearch. Its software helps organizations find, observe, and protect data through search-powered analytics for various cloud-based applications.
Read more on ESTC →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
